Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Testa

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature|October 10, 2008
Playing the system puts self-citation's impact under reviewJames Testa
International Microbiology : the Official Journal of the Spanish Society for Microbiology|July 13, 2006
The Thomson Scientific journal selection processJames Testa
Epidemiology (Cambridge, Mass.)|April 14, 2009
A response from Thomson ReutersJames Testa
Journal of Proteomics|April 17, 2012
Quantitative immunoproteomics analysis reveals novel MHC class I presented peptides in cisplatin-resistant ovarian cancer cellsVivekananda Shetty, Zacharie Nickens, James Testa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2017
CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor EfficacyAnna Wasiuk, James Testa, Jeff Weidlick, et al.
Blood|October 16, 2025
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma modelsKodandaram Pillarisetti, Danlin Yang, Leopoldo Luistro, et al.
Cancer Cell|December 5, 2017
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid RecruitmentAnna H Turaj, Khiyam Hussain, Kerry L Cox, et al.
Mabs|April 19, 2023
"Stapling" scFv for multispecific biotherapeutics of superior propertiesLauren E Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature|October 10, 2008
Playing the system puts self-citation's impact under reviewJames Testa
International Microbiology : the Official Journal of the Spanish Society for Microbiology|July 13, 2006
The Thomson Scientific journal selection processJames Testa
Epidemiology (Cambridge, Mass.)|April 14, 2009
A response from Thomson ReutersJames Testa
Journal of Proteomics|April 17, 2012
Quantitative immunoproteomics analysis reveals novel MHC class I presented peptides in cisplatin-resistant ovarian cancer cellsVivekananda Shetty, Zacharie Nickens, James Testa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2017
CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor EfficacyAnna Wasiuk, James Testa, Jeff Weidlick, et al.
Blood|October 16, 2025
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma modelsKodandaram Pillarisetti, Danlin Yang, Leopoldo Luistro, et al.
Cancer Cell|December 5, 2017
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid RecruitmentAnna H Turaj, Khiyam Hussain, Kerry L Cox, et al.
Mabs|April 19, 2023
"Stapling" scFv for multispecific biotherapeutics of superior propertiesLauren E Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp, et al.
Pageof 1